Crossmark

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis

Published Online: 2021-07-28

Published Print: 2021-12

Authors

Sun, Tingting

Chen, Jing

Sun, Xuechao

Wang, Guonian https://orcid.org/0000-0002-0279-0662
License Information

Text and Data Mining valid from 2021-07-28

Version of Record valid from 2021-07-28
More Information

Article History

Received: 4 June 2021

Accepted: 19 July 2021

First Online: 28 July 2021

Declarations

:

: All the clinical and animal experiments were approved by the Ethics Committee Affiliated to Harbin medical university Cancer Hospital.

: All the participants agreed to publish the final version of this manuscript.

: The authors declare that they have no competing interests.

Document is current